OGEN:US
$0.179
5.471%

Oragenics Inc.
News & Events

Last updated: May 7, 2025, 12:41 AM ET

  1. Oragenics, Inc. to Participate at the 15th Annual Traumatic Brain Injury Conference

    GlobeNewswire APR 23, 2025 8:30 AM EDT
    SARASOTA, Fla., April 23, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biote...
    READ ARTICLE
  2. Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial

    GlobeNewswire APR 9, 2025 8:58 AM EDT
    SARASOTA, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biote...
    READ ARTICLE
  3. Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit

    GlobeNewswire APR 7, 2025 4:30 PM EDT
    SARASOTA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biote...
    READ ARTICLE
  4. Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress

    GlobeNewswire MAR 27, 2025 8:30 AM EDT
    SARASOTA, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biote...
    READ ARTICLE
  5. Oragenics, Inc. Announces Filing of 2024 Annual Report on Form 10-K

    GlobeNewswire MAR 18, 2025 5:33 PM EDT
    SARASOTA, Fla., March 18, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biote...
    READ ARTICLE
  6. Oragenics, Inc. Submits Investigator's Brochure for Phase II Clinical Trial of ONP-002 in Mild Traumatic Brain Injury (mTBI)

    GlobeNewswire MAR 6, 2025 9:30 AM EST
    SARASOTA, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biote...
    READ ARTICLE
  7. Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Present at the Emergencies in Medicine Conference on Advancing Concussion Treatment

    GlobeNewswire FEB 25, 2025 8:30 AM EST
    SARASOTA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotec...
    READ ARTICLE
  8. Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health

    GlobeNewswire FEB 24, 2025 8:30 AM EST
    SARASOTA, Fla., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotec...
    READ ARTICLE
  9. Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment

    GlobeNewswire FEB 11, 2025 8:30 AM EST
    SARASOTA, Fla. and RICHMOND, Va., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE America...
    READ ARTICLE
  10. Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Participate in the 12th Annual Brain Health Summit at the Leigh Steinberg Super Bowl Party 2025

    GlobeNewswire FEB 5, 2025 8:15 AM EST
    SARASOTA, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotec...
    READ ARTICLE

Upcoming Events

Get notified of Oragenics Inc.’s latest announcements, news, and event dates.
  • Upcoming earnings announcement

    Not Available
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available